The TGF-β co-receptor endoglin regulates macrophage infiltration and cytokine production in the irradiated mouse kidney

Radiotherapy and Oncology

Volumn 105, Issue 3, 2012, Pages 313-320

  Scharpfenecker, Marion ^a   Floot, Ben ^a   Russell, Nicola S ^a   Stewart, Fiona A ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Endoglin; Inflammation; Interleukin; Irradiation; Kidney; Macrophage

Indexed keywords

ENDOGLIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL INJURY; BONE MARROW; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FIBROSIS; GENE EXPRESSION; IRRADIATION; MACROPHAGE; MOUSE; NEPHRITIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIATION EXPOSURE; RADIATION INJURY;

ANIMALS; CYTOKINES; DISEASE MODELS, ANIMAL; INTERLEUKIN-1BETA; INTERLEUKIN-6; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY; MACROPHAGES; MICE; MICE, INBRED C57BL; RADIATION INJURIES, EXPERIMENTAL; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA;

EID: 84871202369     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2012.08.021     Document Type: Article

References (58)

1. E.P. Cohen, and M.E. Robbins Radiation nephropathy Semin Nephrol 23 2003 486 499 (Pubitemid 37176694)
2. S. Cheifetz, T. Bellon, and C. Cales Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells J Biol Chem 267 1992 19027 19030
3. A. Gougos, and M. Letarte Identification of a human endothelial cell antigen with monoclonal antibody 44G4 produced against a pre-B leukemic cell line J Immunol 141 1988 1925 1933
4. C. Li, I.N. Hampson, L. Hampson, P. Kumar, C. Bernabeu, and S. Kumar CD105 antagonizes the inhibitory signaling of transforming growth factor beta1 on human vascular endothelial cells FASEB J 14 2000 55 64 (Pubitemid 30051523)
5. J.R. Westphal, H.W. Willems, C.J. Schalkwijk, D.J. Ruiter, and R.M. De Waal A new 180-kDa dermal endothelial cell activation antigen: in vitro and in situ characteristics J Invest Dermatol 100 1993 27 34 (Pubitemid 23035892)
6. L.M. Botella, T. Sanchez-Elsner, and F. Sanz-Rodriguez Transcriptional activation of endoglin and transforming growth factor-beta signaling components by cooperative interaction between Sp1 and KLF6: their potential role in the response to vascular injury Blood 100 2002 4001 4010 (Pubitemid 35396866)
7. X. Ma, M. Labinaz, and J. Goldstein Endoglin is overexpressed after arterial injury and is required for transforming growth factor-beta-induced inhibition of smooth muscle cell migration Arterioscler Thromb Vasc Biol 20 2000 2546 2552
8. N.G. Docherty, J.M. Lopez-Novoa, and M. Arevalo Endoglin regulates renal ischaemia-reperfusion injury Nephrol Dial Transplant 21 2006 2106 2119 (Pubitemid 44295035)
9. H.M. Arthur, J. Ure, and A.J. Smith Endoglin, an ancillary TGFbeta receptor, is required for extraembryonic angiogenesis and plays a key role in heart development Dev Biol 217 2000 42 53 (Pubitemid 30046798)
10. A. Bourdeau, D.J. Dumont, and M. Letarte A murine model of hereditary hemorrhagic telangiectasia J Clin Invest 104 1999 1343 1351
11. D.Y. Li, L.K. Sorensen, and B.S. Brooke Defective angiogenesis in mice lacking endoglin Science 284 1999 1534 1537
12. K.A. McAllister, K.M. Grogg, and D.W. Johnson Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1 Nat Genet 8 1994 345 351
13. F. Sanz-Rodriguez, L. Fernandez, and R. Zarrabeitia Mutation analysis in Spanish patients with hereditary hemorrhagic telangiectasia: deficient endoglin up-regulation in activated monocytes Clin Chem 50 2004 2003 2011 (Pubitemid 39425836)
14. E. Torsney, R. Charlton, D. Parums, M. Collis, and H.M. Arthur Inducible expression of human endoglin during inflammation and wound healing in vivo Inflamm Res 51 2002 464 470 (Pubitemid 35034452)
15. M. Prieto, A. Rodriguez-Pena, and M. Arevalo Effect of the long-term treatment with trandolapril on endoglin expression in rats with experimental renal fibrosis induced by renal mass reduction Kidney Blood Press Res 28 2005 32 40 (Pubitemid 40069635)
16. M. Prieto, A.B. Rodriguez-Pena, and A. Duwel Temporal changes in renal endoglin and TGF-beta1 expression following ureteral obstruction in rats J Physiol Biochem 61 2005 457 467 (Pubitemid 43091764)
17. P. Roy-Chaudhury, J.G. Simpson, and D.A. Power Endoglin, a transforming growth factor-beta-binding protein, is upregulated in chronic progressive renal disease Exp Nephrol 5 1997 55 60 (Pubitemid 27105124)
18. M. Scharpfenecker, B. Floot, N.S. Russell, P. Ten Dijke, and F.A. Stewart Endoglin haploinsufficiency reduces radiation-induced fibrosis and telangiectasia formation in mouse kidneys Radiother Oncol 92 2009 484 491
19. P. Lastres, T. Bellon, and C. Cabanas Regulated expression on human macrophages of endoglin, an Arg-Gly-Asp-containing surface antigen Eur J Immunol 22 1992 393 397
20. P.J. O'Connell, A. McKenzie, N. Fisicaro, S.P. Rockman, M.J. Pearse, and A.J. d'Apice Endoglin: a 180-kD endothelial cell and macrophage restricted differentiation molecule Clin Exp Immunol 90 1992 154 159
21. L.J. Zhou, and T.F. Tedder Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily J Immunol 154 1995 3821 3835
22. A.R. Chade Renovascular disease, microcirculation and the progression of renal injury: role of angiogenesis Am J Physiol Regul Integr Comp Physiol 2011
23. C. Chatziantoniou, and J.C. Dussaule Insights into the mechanisms of renal fibrosis: is it possible to achieve regression? Am J Physiol Renal Physiol 289 2005 F227 F234
24. H.J. Anders, and M. Ryu Renal microenvironments and macrophage phenotypes determine progression or resolution of renal inflammation and fibrosis Kidney Int 80 2011 915 925
25. N. Esiashvili, K.Y. Chiang, M.D. Hasselle, C. Bryant, R.H. Riffenburgh, and A.C. Paulino Renal toxicity in children undergoing total body irradiation for bone marrow transplant Radiother Oncol 90 2009 242 246
26. N.J. Tarbell, E.C. Guinan, L. Chin, P. Mauch, and H.J. Weinstein Renal insufficiency after total body irradiation for pediatric bone marrow transplantation Radiother Oncol 18 1990 139 142
27. S. Kost, W. Dorr, K. Keinert, F.H. Glaser, G. Endert, and T. Herrmann Effect of dose and dose-distribution in damage to the kidney following abdominal radiotherapy Int J Radiat Biol 78 2002 695 702 (Pubitemid 34971773)
28. J.C. Cheng, T.E. Schultheiss, and J.Y. Wong Impact of drug therapy, radiation dose, and dose rate on renal toxicity following bone marrow transplantation Int J Radiat Oncol Biol Phys 71 2008 1436 1443
29. E.P. Jansen, M.P. Saunders, and H. Boot Prospective study on late renal toxicity following postoperative chemoradiotherapy in gastric cancer Int J Radiat Oncol Biol Phys 67 2007 781 785 (Pubitemid 46215865)
30. S. Welz, T. Hehr, C. Kollmannsberger, C. Bokemeyer, C. Belka, and W. Budach Renal toxicity of adjuvant chemoradiotherapy with cisplatin in gastric cancer Int J Radiat Oncol Biol Phys 69 2007 1429 1435 (Pubitemid 350116407)
31. G.Y. Yang, K.S. May, and R.V. Iyer Renal atrophy secondary to chemoradiotherapy of abdominal malignancies Int J Radiat Oncol Biol Phys 78 2010 539 546
32. E.P. Cohen, A.A. Irving, and W.R. Drobyski Captopril to mitigate chronic renal failure after hematopoietic stem cell transplantation: a randomized controlled trial Int J Radiat Oncol Biol Phys 70 2008 1546 1551 (Pubitemid 351417757)
33. M. Verheij, L.G. Dewit, R.A. Valdes Olmos, and L. Arisz Evidence for a renovascular component in hypertensive patients with late radiation nephropathy Int J Radiat Oncol Biol Phys 30 1994 677 683 (Pubitemid 24304480)
34. L.M. Ortega, and A. Fornoni Role of cytokines in the pathogenesis of acute and chronic kidney disease, glomerulonephritis, and end-stage kidney disease Int J Interferon Cytokine Mediator Res 2 2010 49 62
35. T.A. Wynn, and L. Barron Macrophages: master regulators of inflammation and fibrosis Semin Liver Dis 30 2010 245 257
36. B. Rodriguez-Iturbe, H. Pons, J. Herrera-Acosta, and R.J. Johnson Role of immunocompetent cells in nonimmune renal diseases Kidney Int 59 2001 1626 1640 (Pubitemid 32336778)
37. Y. Wang, and D.C. Harris Macrophages in renal disease J Am Soc Nephrol 22 2011 21 27
38. K. Sean Eardley, and P. Cockwell Macrophages and progressive tubulointerstitial disease Kidney Int 68 2005 437 455 (Pubitemid 43323099)
39. F. Chow, E. Ozols, D.J. Nikolic-Paterson, R.C. Atkins, and G.H. Tesch Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury Kidney Int 65 2004 116 128 (Pubitemid 38037496)
40. K. Kitagawa, T. Wada, and K. Furuichi Blockade of CCR2 ameliorates progressive fibrosis in kidney Am J Pathol 165 2004 237 246 (Pubitemid 38821831)
41. S.K. Cho, A. Bourdeau, M. Letarte, and J.C. Zuniga-Pflucker Expression and function of CD105 during the onset of hematopoiesis from Flk1(+) precursors Blood 98 2001 3635 3642
42. A. Mantovani, and E. Dejana Cytokines as communication signals between leukocytes and endothelial cells Immunol Today 10 1989 370 375 (Pubitemid 19242062)
43. A. Mantovani, F. Bussolino, and E. Dejana Cytokine regulation of endothelial cell function FASEB J 6 1992 2591 2599
44. J.S. Pober, and W.C. Sessa Evolving functions of endothelial cells in inflammation Nat Rev Immunol 7 2007 803 815 (Pubitemid 47480307)
45. S. Wassmann, M. Stumpf, and K. Strehlow Interleukin-6 induces oxidative stress and endothelial dysfunction by overexpression of the angiotensin II type 1 receptor Circ Res 94 2004 534 541 (Pubitemid 38326289)
46. M.J. Hung, W.J. Cherng, M.Y. Hung, H.T. Wu, and J.H. Pang Interleukin-6 inhibits endothelial nitric oxide synthase activation and increases endothelial nitric oxide synthase binding to stabilized caveolin-1 in human vascular endothelial cells J Hypertens 28 2010 940 951
47. M. Saura, C. Zaragoza, C. Bao, B. Herranz, M. Rodriguez-Puyol, and C.J. Lowenstein Stat3 mediates interleukin-6 inhibition of human endothelial nitric-oxide synthase expression J Biol Chem 281 2006 30057 30062 (Pubitemid 44537013)
48. B. Szotowski, S. Antoniak, W. Poller, H.P. Schultheiss, and U. Rauch Procoagulant soluble tissue factor is released from endothelial cells in response to inflammatory cytokines Circ Res 96 2005 1233 1239 (Pubitemid 40962100)
49. M. Romano, M. Sironi, and C. Toniatti Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment Immunity 6 1997 315 325 (Pubitemid 27148598)
50. K. Rusai, H. Huang, and N. Sayed Administration of interleukin-1 receptor antagonist ameliorates renal ischemia-reperfusion injury Transpl Int 21 2008 572 580 (Pubitemid 351611620)
51. H.Y. Lan, D.J. Nikolic-Paterson, M. Zarama, J.L. Vannice, and R.C. Atkins Suppression of experimental crescentic glomerulonephritis by the interleukin-1 receptor antagonist Kidney Int 43 1993 479 485 (Pubitemid 23162845)
52. L.K. Jones, K.M. O'Sullivan, and T. Semple IL-1RI deficiency ameliorates early experimental renal interstitial fibrosis Nephrol Dial Transplant 24 2009 3024 3032
53. M.L. Kielar, R. John, and M. Bennett Maladaptive role of IL-6 in ischemic acute renal failure J Am Soc Nephrol 16 2005 3315 3325 (Pubitemid 46179335)
54. Y. Nechemia-Arbely, D. Barkan, and G. Pizov IL-6/IL-6R axis plays a critical role in acute kidney injury J Am Soc Nephrol 19 2008 1106 1115
55. N.S. Patel, P.K. Chatterjee, and R. Di Paola Endogenous interleukin-6 enhances the renal injury, dysfunction, and inflammation caused by ischemia/reperfusion J Pharmacol Exp Ther 312 2005 1170 1178 (Pubitemid 40293778)
56. M.A. Brach, and F. Herrmann Interleukin 6: presence and future Int J Clin Lab Res 22 1992 143 151
57. G.H. Tesch, N. Yang, and H. Yu Intrinsic renal cells are the major source of interleukin-1 beta synthesis in normal and diseased rat kidney Nephrol Dial Transplant 12 1997 1109 1115 (Pubitemid 27230543)
58. M.O. Li, Y.Y. Wan, S. Sanjabi, A.K. Robertson, and R.A. Flavell Transforming growth factor-beta regulation of immune responses Annu Rev Immunol 24 2006 99 146